News for hackers. Stuff that matters.
Re:Rapamycin, drug used in cancer therapy, emerges as powerf... by webnrrd2k on Wednesday August 31, 2022 @02:29PM (#32666351)
Why don't insurance companies fund some of this research? Honestly, I don't know.

Wouldn't they want to get treatment costs down? Large HMOs, especially, have motivation to control treatment costs, and access to the patients, data, etc... to make it work.

Re:Rapamycin, drug used in cancer therapy, emerges as powerf... by ddingus on Thursday September 01, 2022 @03:35AM (#32673198)
Delivering care counts toward their margins, regulated by the ACA. I forget the exact number, but it is 80 percent to be spent on care, something like that.

The key thing is more care = more dollars = more in the bank.

One response to that legislation was insurers buying care providers.